Profil
Tom Reeves is currently the President & Chief Executive Officer at Ripple Therapeutics Corp.
He is also a Director at Soricimed Biopharma, Inc. since 2018.
Postes actifs de Tom Reeves
| Sociétés | Poste | Début |
|---|---|---|
Soricimed Biopharma, Inc.
 Soricimed Biopharma, Inc. BiotechnologyHealth Technology Soricimed Biopharma, Inc. develops novel cancer therapeutics and diagnostics. Its programs include SOR-C13 and Peptide-Drug Conjugate. The company was founded by Jack Stewart and Paul Gunn in 2005 and is headquartered in Moncton, Canada. | Directeur/Membre du Conseil | 04/09/2018 |
| Ripple Therapeutics Corp. | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Soricimed Biopharma, Inc.
Soricimed Biopharma, Inc. BiotechnologyHealth Technology Soricimed Biopharma, Inc. develops novel cancer therapeutics and diagnostics. Its programs include SOR-C13 and Peptide-Drug Conjugate. The company was founded by Jack Stewart and Paul Gunn in 2005 and is headquartered in Moncton, Canada. | Health Technology |
| Ripple Therapeutics Corp. |
